COMPANY
Triangle Biotechnology
Funding and NIH signals
- NIH award NIH awarded $1M (SBIR commercialization 1SB1AI197360-01, new, notice Jul 20, 2026). NIH RePORTER 1SB1AI197360-01 (Jul 20, 2026)
Evidence (1 event)
- Jul 20, 2026 · NIH RePORTER 1SB1AI197360-01
Organization: TRIANGLE BIOTECHNOLOGY, INC.; City/State: Chapel Hill, NC; Project number: 1SB1AI197360-01; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-07-20; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Commercializing nanodroplet technology to improve diagnostic sensitivity for difficult-to-lyse microbial samples; Organization type: Domestic For-Profits
- Jul 20, 2026 · NIH RePORTER 1SB1AI197360-01
Timeline
- Grant Government grant — SBIR: $1M (annual award, as published), announced Jul 20, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Funding
- Government grant — SBIR: $1M (annual award, as published), announced Jul 20, 2026. Agency: NIH/NIAID. Source: government award database. source ↗